nsc 664704 has been researched along with Acoustic Trauma in 1 studies
kenpaullone: inhibits CDK1/cyclin B; structure in first source
kenpaullone : An indolobenzazepine that is paullone in which the hydrogen at position 9 is replaced by a bromo substituent. It is an ATP-competitive inhibitor of cyclin-dependent kinases (CDKs) and glycogen synthase kinase 3beta (GSK3beta).
Acoustic Trauma: Usually refer to hearing loss due to a single noise event such as an explosion or shotgun blast.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Teitz, T | 1 |
| Fang, J | 1 |
| Goktug, AN | 1 |
| Bonga, JD | 1 |
| Diao, S | 1 |
| Hazlitt, RA | 1 |
| Iconaru, L | 1 |
| Morfouace, M | 1 |
| Currier, D | 1 |
| Zhou, Y | 1 |
| Umans, RA | 1 |
| Taylor, MR | 1 |
| Cheng, C | 1 |
| Min, J | 1 |
| Freeman, B | 1 |
| Peng, J | 1 |
| Roussel, MF | 1 |
| Kriwacki, R | 1 |
| Guy, RK | 1 |
| Chen, T | 1 |
| Zuo, J | 1 |
1 other study available for nsc 664704 and Acoustic Trauma
| Article | Year |
|---|---|
CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss.
Topics: Animals; Benzazepines; Cell Death; Cell Line, Tumor; Cisplatin; Cyclin-Dependent Kinase 2; Cytoprote | 2018 |